↓ Skip to main content

Ketamine as an adjuvant to opioids for cancer pain

Overview of attention for article published in Cochrane database of systematic reviews, November 2012
Altmetric Badge

About this Attention Score

  • In the top 5% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (96th percentile)
  • High Attention Score compared to outputs of the same age and source (90th percentile)

Mentioned by

blogs
1 blog
twitter
35 tweeters
facebook
2 Facebook pages
f1000
1 research highlight platform

Citations

dimensions_citation
83 Dimensions

Readers on

mendeley
65 Mendeley
citeulike
1 CiteULike
You are seeing a free-to-access but limited selection of the activity Altmetric has collected about this research output. Click here to find out more.
Title
Ketamine as an adjuvant to opioids for cancer pain
Published in
Cochrane database of systematic reviews, November 2012
DOI 10.1002/14651858.cd003351.pub2
Pubmed ID
Authors

Bell RF, Eccleston C, Kalso EA, Bell, Rae F, Eccleston, Christopher, Kalso, Eija A

Abstract

This is an update of the original review published in Issue 1, 2003. Ketamine is a commonly used anaesthetic agent, and in subanaesthetic doses is also given as an adjuvant to opioids for the treatment of cancer pain, particularly when opioids alone prove to be ineffective. Ketamine is known to have psychotomimetic (including hallucinogenic), urological and hepatic adverse effects.

Twitter Demographics

The data shown below were collected from the profiles of 35 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 65 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
Finland 1 2%
Australia 1 2%
Unknown 63 97%

Demographic breakdown

Readers by professional status Count As %
Other 10 15%
Student > Master 10 15%
Student > Ph. D. Student 7 11%
Student > Bachelor 7 11%
Researcher 6 9%
Other 17 26%
Unknown 8 12%
Readers by discipline Count As %
Medicine and Dentistry 37 57%
Psychology 4 6%
Agricultural and Biological Sciences 3 5%
Nursing and Health Professions 3 5%
Business, Management and Accounting 2 3%
Other 8 12%
Unknown 8 12%

Attention Score in Context

This research output has an Altmetric Attention Score of 34. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 21 July 2017.
All research outputs
#434,931
of 12,627,091 outputs
Outputs from Cochrane database of systematic reviews
#1,422
of 10,385 outputs
Outputs of similar age
#3,521
of 115,340 outputs
Outputs of similar age from Cochrane database of systematic reviews
#10
of 100 outputs
Altmetric has tracked 12,627,091 research outputs across all sources so far. Compared to these this one has done particularly well and is in the 96th percentile: it's in the top 5% of all research outputs ever tracked by Altmetric.
So far Altmetric has tracked 10,385 research outputs from this source. They typically receive a lot more attention than average, with a mean Attention Score of 20.1. This one has done well, scoring higher than 86% of its peers.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 115,340 tracked outputs that were published within six weeks on either side of this one in any source. This one has done particularly well, scoring higher than 96% of its contemporaries.
We're also able to compare this research output to 100 others from the same source and published within six weeks on either side of this one. This one has done particularly well, scoring higher than 90% of its contemporaries.